Results 11 to 20 of about 60,520 (265)

Reboxetine versus other antidepressive agents for depression [PDF]

open access: greenCochrane Database Syst Rev, 2018
Churchill R   +7 more
europepmc   +3 more sources

The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis. [PDF]

open access: goldInt J Environ Res Public Health, 2018
Schweiger JU   +6 more
europepmc   +3 more sources

Bupropion versus other antidepressive agents for depression [PDF]

open access: greenCochrane Database Syst Rev, 2020
Furukawa T   +6 more
europepmc   +3 more sources

Milnacipran versus other antidepressive agents for depression. [PDF]

open access: greenCochrane Database Syst Rev, 2009
Nakagawa A   +7 more
europepmc   +3 more sources

Escitalopram versus other antidepressive agents for depression. [PDF]

open access: greenCochrane Database Syst Rev, 2009
Cipriani A   +7 more
europepmc   +3 more sources

Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov [PDF]

open access: yesTranslational Psychiatry
Major depressive disorder (MDD), commonly known as depression, affects over 300 million people worldwide as of 2018 and presents a wide range of clinical symptoms.
Eugenia D. Namiot   +5 more
doaj   +2 more sources

Influence of functional health literacy on adherence to antidepressant treatment [PDF]

open access: yesRevista Gaúcha de Enfermagem, 2022
Objective To verify the influence of patients’ level of functional health literacy on adherence to antidepressant treatment. Method Cross-sectional study, carried out in pharmacies of the Municipal Health Department of Marília-SP, in 2020/2021.
Alessandro Magon de Sá   +3 more
doaj   +1 more source

Natural Psychoplastogens As Antidepressant Agents [PDF]

open access: yesMolecules, 2020
Increasing prevalence and burden of major depressive disorder presents an unavoidable problem for psychiatry. Existing antidepressants exert their effect only after several weeks of continuous treatment. In addition, their serious side effects and ineffectiveness in one-third of patients call for urgent action.
Jakub Benko, Stanislava Vranková
openaire   +4 more sources

Beneficial effects of arthrocen on neuroinflammation and behavior like depression in stroke in a murine model

open access: yesFood Science &Nutrition, Volume 11, Issue 1, Page 527-534, January 2023., 2023
Following oral administration of arthrocen supplement in post‐stroke depression model, the study recommended a novel protective effect by arthrocen on neuroinflammation due to stroke. It may play an antidepressant role through anti‐inflammatory as well as improved activity and mobility in mice‐induced stroke.
Ramin Goudarzi   +5 more
wiley   +1 more source

Phenolic Acids as Antidepressant Agents

open access: yesNutrients, 2022
Depression is a psychiatric disorder affecting the lives of patients and their families worldwide. It is an important pathophysiology; however, the molecular pathways involved are not well understood. Pharmacological treatment may promote side effects or be ineffective.
Maria Lúcia da Silva Cordeiro   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy